Raphael Ceccaldi

Molecular Biology · 2015–2016

A researcher in the Science corpus: 4 papers; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 75 citations into it; #11,558 of 17,773 by trust here, #10,695 by citations
• Oncology — 43 citations into it
• Reproductive Medicine — 23 citations into it
• Pathology and Forensic Medicine — 8 citations into it

Whom Raphael Ceccaldi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Bryan T. J. Hennessy
2. L. Kelland
3. Mitch McVey
4. Gordon B. Mills

Who trusts Raphael Ceccaldi overall

1. Nimrat Chatterjee
2. Graham C. Walker
3. Ruixue Huang
4. Mark J. O'Connor
5. Yves Pommier

Papers from Raphael Ceccaldi's perspective

Ordered by how strongly the researchers Raphael Ceccaldi trusts endorse each paper. Same corpus, a different order for every researcher.

1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
2. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (Nature)
3. Functional interaction between PARP‐1 and PARP‐2 in chromosome stability and embryonic development in mouse (EMBO Journal)
4. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers (Nature Structural &Molecular Biology)
5. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. (The Lancet Oncology)
6. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (EMBO Molecular Medicine)
7. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways (Nucleic Acids Research)
8. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer (British Journal of Cancer)
9. Involvement of Poly(ADP-ribose) Polymerase-1 and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks Rejoining* (Journal of Biological Chemistry)
10. Whole–genome characterization of chemoresistant ovarian cancer (Nature)

Their papers

• Repair Pathway Choices and Consequences at the Double-Strand Break (2015) — 1,377 citations
• Homologous recombination deficiency: Exploiting the fundamental vulnerability of ovarian cancer (2015) — 820 citations
• The Fanconi anaemia pathway: new players and new functions (2016) — 642 citations
• Homologous recombination-deficient tumors are hyper-dependent on POLQ-mediated repair (2015) — 684 citations